Loading data for ERNA — first visit, this takes a few seconds.

알림

Ernexa Therapeutics Inc. (ERNA)

NasdaqCM: ERNA · 실시간 가격 · USD

4.06

-0.21 (-4.92%)

종가 기준: Aug 18, 2026, 3:59 PM

-4.92% (1D)

매수호가	n/a
시가총액	4.74M
매출 (ttm)	n/a
순이익 (ttm)	-12.27M
베타	2.56
EPS (ttm)	-0.4
P/E (ttm)	n/a
선행 P/E	-0.42
P/B (ttm)	0.69
P/S (ttm)	n/a
Earnings Date	Apr 15, 2022

매도호가	n/a
거래량	27,158
평균 거래량 (20일)	488,975
시가	4.24
전일 종가	4.27
일중 범위	4.02 - 4.40
52주 범위	3.18 - 71.50
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

ERNA 소개

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a li...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Aug 29, 1991

직원 수 5

상장 거래소 NasdaqCM

티커 ERNA

웹사이트 https://www.ernexatx.com

전체 기업 정보

재무 실적

2025년 Ernexa Therapeutics의 매출은 0로, 전년 582K 대비 -100% 감소했습니다. 순이익은 -14.08M로, -68.38% 감소했습니다.

재무제표

어닝 서프라이즈

Ernexa Therapeutics가 Aug 6, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -3.4 예상치 하회 -0.10, 및 99.73% 전년 대비 성장.

다음 실적 발표

Ernexa Therapeutics Inc.의 실적 발표 예정일은 Apr 15, 2022, 장 마감 후입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1개월 전 · InvestorsHub

Ernexa Therapeutics shares soar 30% after independent study validates cancer therapy (ERNA)

Ernexa Therapeutics (NASDAQ:ERNA) shares surged 30% on Wednesday after the company announced positive independent preclinical data supporting its lead cell therapy candidate, ERNA-101, for the treatme...

3개월 전 · Zacks

ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know

Ernexa Therapeutics stock soars 140% in a month as ERNA-101 shows complete tumor clearance and long-term survival in pre-clinical ovarian cancer models.

3개월 전 · 24/7 Wall St.

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners

President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, w...

3개월 전 · InvestorsHub

Ernexa Therapeutics (ERNA) Preclinical Data Shows 100% Survival and Complete Tumor Clearance in Ovarian Cancer Models

Ernexa Therapeutics reported new preclinical findings showing its ERNA-101 cell therapy candidate achieved complete tumor elimination and long-term survival in ovarian cancer models when combined with...

9개월 전 · Associated Press Finance

BC-Most Active Stocks

YY Group Holdings Ltd. 56,330,377 0.4678

Ernexa Therapeutics Inc. (ERNA)